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Abstract: Background and objectives: Diabetes mellitus (DM) stands out among the most important 
public health problems worldwide since it represents a high burden on health systems and is 
associated with higher hospitalization rates, and a higher incidence of cardiovascular diseases. 
Amputations are among the most common complications, leading to disability and increasing care 
costs. This research aims to analyze the prevalence of DM-related amputations, comorbidities and 
associated risk factors in the diabetic population residing in the State of Espírito Santo, Brazil. 
Materials and Methods: This is a quantitative, exploratory, cross-sectional study with a time series 
design and the use of secondary data registered and followed by the system of Registration and 
Monitoring of Hypertension and Diabetes—SisHiperdia. Results: The sample consisted of 64,196 
diabetic patients, out of them, 3.9% had type 1 DM, 10.9% with type 2 DM, and 85.2% with DM 
coexisting with hypertension. Most were female (66.6%), aged 40 to 59 years (45.6%), and 60 years 
and older (45.2%). The prevalence of DM-related amputations in the analyzed sample was 1.2% in 
type 1 DM, 1.5% in type 2 DM, and 2.2% in concomitant DM and hypertension. Higher amputation 
rates were observed in males in the age group above 60 years in type 1 DM and type 2 DM and were 
slightly higher in the age groups up to 29 years in DM with hypertension. A higher prevalence of 
amputation was related to smoking, physical inactivity, acute myocardial infarction (AMI), stroke, 
chronic kidney disease (CKD), and diabetic foot (DF) in all types of DM. Conclusions: The present 
study showed a significant prevalence of DM-related amputations. An increased prevalence was 
evidenced when correlated with smoking, physical inactivity, AMI, stroke, CKD, and DF with 
significant statistical associations, except for a sedentary lifestyle in type 1 DM. 
Keywords: diabetes mellitus; amputation; health promotion 
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1. Introduction 
Diabetes mellitus (DM) stands out among the most important public health problems. It is 
among the top ten causes of death worldwide, reaching approximately four million deaths of people 
aged 20 to 79 years in 2017. In the same year, the prevalence of DM was estimated at 8.8% of the 
world population aged 20 to 79 years, totaling around 425 million people, with a trend for the year 
2,045 of 9.9%, reaching 628.6 million citizens worldwide. Together with cardiovascular disease, 
cancer, and respiratory disease, it represents over 80% of all premature deaths from chronic 
noncommunicable diseases (NCDs) [1]. 
DM imposes high burden on health systems and is associated with higher hospitalization rates, 
higher utilization of health services, as well as a higher incidence of cardiovascular and 
cerebrovascular diseases, blindness, renal insufficiency, and non-traumatic lower-limb amputations. 
Diabetic foot ulcers and associated amputations are among the most common complications, leading 
to disability and increasing care costs [2,3]. Foot ulcers affect 4% to 10% of people with DM. About 
40% to 60% of non-traumatic lower-limb amputations occur in these patients, and 85% of them are 
preceded by foot ulcers [4,5]. 
A study carried out with 21 countries from the Organization for Economic Cooperation and 
Development (OECD) showed an average rate of major amputations equal to 7.5 per 100,000 in the 
general population and 128.3 per 100,000 in the diabetic population. For minor amputations, the 
standardized rate for age and sex was 11.1 per 100,000 in the general population and 184.3 per 100,000 
in the diabetic population [6]. 
The frequency of amputation is 10 to 20 times higher in the diabetic population compared to 
non-diabetics [7]. Worldwide, one million individuals with DM suffer lower limb amputation 
annually, accounting for about three amputations per minute [8]. 
In Brazil, between 2011 and 2016, 102,056 amputation surgeries were performed by the National 
Health System (SUS—Sistema Único de Saúde); out of them, 70% were diabetic individuals, with 94% 
of these being lower-limb amputations [9]. Estimates indicate that for a population of 7.12 million 
diabetics, 484,500 would develop foot ulcers, 169,600 would be admitted to hospitals and 80,900 
would suffer some kind of amputation, of them, 21,700 would die as a result [10]. 
A study on lower-limb amputations in the metropolitan region of Rio de Janeiro, Brazil, showed 
an incidence of 13.9 per 100,000 inhabitants for the general population, and 180.6 per 
100,000inhabitants for the diabetic population [11].  
Individuals with DM suffer lower limb amputations for many reasons, such as age, disease 
duration, prolonged hyperglycemia, dyslipidemia, smoking, excessive use of alcohol, infections, 
peripheral neuropathy, ulcers, and inadequate metabolic control of the disease [12,13]. 
Peripheral arterial disease (PAD) and lower extremity diabetic peripheral neuropathy (DPN) are 
associated with DM-related amputations [8]. The survival rate for DM patients in the three years 
following an amputation is about 50% [12]. 
DPN can lead to loss of protective sensitivity, double the likelihood of foot ulcer development, 
and triple the risk of lower extremity amputation [14–17].  
From this perspective, it has become evident that there is a need for commitment by government 
leaders and healthcare managers to create mechanisms that minimize the onset, as well as the 
aggravation of DM [18]. 
These efforts should be directed at both the reorganization of care for people with DM and the 
provision of necessary inputs for disease monitoring, with the aim of reducing the costs of early non-
detection and complications related to lack of metabolic control [19]. 
Multi-professional care for people with DM and diabetic foot (DF) should be considered in 
public health policies, since better results have been achieved when the approach is given by multi-
professional teams, sharing knowledge and expertise, reducing DM amputation rates [20]. 
The collection of data regarding complications of DM, the identification of the epidemiological 
profile, and the prevalence of amputations, as well as their correlations, are of great value for the 
elaboration, implementation, and evaluation of the results of public policies and health promotion 
programs. For these reasons, the present study aims to analyze the prevalence of DM-related 
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amputations, comorbidities, and related risk factors in the diabetic population living in the state of 
Espírito Santo, Brazil. 
2. Materials and Methods 
2.1. Study Design 
This is a descriptive cross-sectional study [21], incorporating a time series design and the use of 
secondary data on the morbidity of individuals with DM who underwent DM-related amputation, 
residing in the state of Espírito Santo, Brazil, registered and followed by the System of Registration 
and Follow-up of Hypertension and Diabetes—SisHiperdia. 
2.2. Study Location and Period 
Data were collected from the place of residence of individuals registered in the system. The unit 
of analysis selected was the State of Espírito Santo, Brazil. The data corresponded to the period 
between 2003 and 2012. 
The period analyzed is justified since SisHiperdia was discontinued at the beginning of 2013, 
with no more recent data available. Unfortunately, there is no other information system in the country 
with similar data. However, the data used in this survey are complete, and reliably represents the 
profile of the population analyzed. This information platform contains important indicators of the 
results of public health policies implemented by the Brazilian government for monitoring 
hypertension and DM which had a significant impact on the current population residing in the State 
of Espírito Santo.  
The selection of this database is due to the representativeness and completeness of its 
information, making it appropriate to measure the magnitude of the problem in question and the 
possibility of directing the public power to the construction of effective strategies for monitoring 
diabetes and its complications. 
2.3. Study Population and Eligibility Criteria 
All individuals with type I DM, type II DM, and DM with concomitant arterial hypertension 
who underwent amputation due to DM, were a resident in the state of Espírito Santo, and were 
registered and followed by the SisHiperdia in the period of 2003 to 2012, were included. 
No individuals were excluded from the sample. Individuals who reported as diabetic with 
concomitant arterial hypertension in SisHiperdia were not stratified by the type of diabetes (type I 
DM or type II DM). 
The database includes amputations related to Diabetes but does not differentiate them from 
major and minor amputations, hence it is not possible to analyze these data separately. However, this 
fact did not compromise the objectives of this research. 
2.4. Data Collection 
Data were extracted from the SisHiperdia, provided by the Department of Informatics of the 
National Health System—DATASUS [22]. Two independent researchers organized the data in a 
Microsoft® Excel version 15.0 spreadsheet. Then, an exploratory analysis was performed to recognize 
the variables and correct possible errors or inconsistencies in data entry. Once the necessary 
corrections were made, the data were organized and analyzed by applying descriptive statistics. 
SisHiperdia is a health program monitoring system established by the Ministry of Health in 2002, 
as part of the Reorganization Plan for Arterial Hypertension and Diabetes Mellitus Care, 
consolidating itself as a platform for registration and monitoring of patients with hypertension and 
diabetes mellitus, assisted by the team of Primary Care of the SUS. This database generates 
information on the epidemiological profile of the population with hypertension and diabetes 
mellitus, which is available for professionals and managers of municipal and state departments and 
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the Ministry of Health. This information is publicly accessible with the exception of patient 
identification [23]. 
This system presents several options for the use of its data and makes it possible to investigate 
whether the population at risk is adequately assisted, to know the demographic and epidemiological 
profile of the affected community, to verify the prevalence of risk factors, concomitant diseases, and 
complications, monitor the clinical quality of care provided and determine the real parameters of the 
continuous supply of medicines. Moreover, it enables social control through information to analyze 
access, coverage and quality of care [23,24]. 
Data collected by municipalities are transferred via the internet, consolidated by the Ministry of 
Health, and made available monthly for public access on the DATASUS website, allowing access to 
reports with operational, managerial, and epidemiological indicators predefined by the National 
Coordination of the Hypertension Program and Diabetes (CNPHD). Users can also access key system 
database information, calculate indicators and produce charts and maps from their own fast tabs 
using the free Tabnet and Tabwin applications available from DATASUS [23,24]. 
2.5. Data Analysis 
The prevalence of DM amputation, stratified by type I DM, type II DM, and DM with 
concomitant arterial hypertension, by gender and age group, by comorbidities and associated risk 
factors (smoking, physical inactivity, overweight, acute myocardial infarction (AMI), stroke, chronic 
kidney disease (CKD), and DF) were calculated and expressed as a percentage using the direct 
method. 
Prevalence ratios (PR) were calculated, and associations between amputations with risk factors 
and comorbidities reported in the system were analyzed. The dependent variable (y) was DM 
amputation, while the independent variables (x) were gender, age, smoking, physical inactivity, 
overweight, AMI, stroke, CDK, and DF. Associations were analyzed by Pearson’s chi-squared test 
and the Yates correction, using the Stata®14.0 statistical program and considering a 95% confidence 
level. 
2.6. Ethical and Legal Aspects of the Research 
This study involved only the description and analysis of secondary data collected from the 
SisHiperdia, informed by DATASUS. All of these sources of information are in the public domain. 
No individually identifiable information was obtained for this study. 
3. Results 
The sample consisted of a total of 64,196 diabetic individuals, residents in the state of Espírito 
Santo. Table 1 illustrates the characterization of the sample by type of DM, gender, and age group.  
Table 1. The total number of diabetic individuals registered and followed by the SisHiperdia in 
Espírito Santo from 2003 to 2012, stratified by type of Diabetes Mellitus (DM), gender, and age group. 
Variables  Total % 









Sample  64,196 100 2512 3.9 6995 10.9 54,689 85.2 
Gender 
Male 21,416 33.4 1138 45.3 2875 41.1 17,403 31.8 
Female 42,780 66.6 1374 54.7 4120 58.9 37,286 68.2 
Age group 
Up to 19 696 1.1 391 15.6 99 1.4 206 0.4 
20 to 39 5219 8.1 672 26.8 995 14.2 3552 6.5 
40 to 59 29,282 45.6 922 36.7 3,767 53.9 24,593 45.0 
60 of age or 
older 
28,999 45.2 527 21.0 2,134 30.5 26,338 48.2 
Source: SisHiperdia (Department of Informatics of the National Health System - DATASUS), 2019. 
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3.1. Prevalence of DM-Related Amputations 
The prevalence rates of DM-related amputations stratified by type of DM, gender, age group, 
and associated risk factors and comorbidities are shown in Tables 2–4. 
The prevalence of DM-related amputations in the analyzed sample was 1.2% (n = 29) in type 1 
DM, 1.5% (n = 104) in type 2 DM, and 2.2% (n = 1224) in DM with hypertension. Higher amputation 
rates were observed in males over the age of 60 years in type 1 DM and type 2 DM and were slightly 
higher in the age group up to 29 years in DM with hypertension.  
The correlation between amputations and associated risk factors and comorbidities showed a 
higher prevalence of smoking, sedentary lifestyle, AMI, stroke CKD, and DF in all types of DM, with 
a statistically significant association, except for sedentary lifestyle in type 1 DM. The prevalence of 
amputations was lower in the overweight population with type 1 DM, type 2 DM, and coexistent 
hypertension and DM, showing a statistically significant association in DM with hypertension. 
Table 2. Prevalence% of DM-related amputations in the type 1 DM population, stratified by gender, 
age group, smoking, physical inactivity, overweight, acute myocardial infarction (AMI), stroke, 




n (P%) 95% CI 
No 
n (P%) 95% CI 
PR (95%CI) “p” 
Amputation 29 (1.2) 0.8–1.7 2483 (98.8) 98.3–99.2   
Gender 
Male 21 (1.8) 1.2–2.9 1117 (98.2) 97.1–98.8 
3.17 (1.41–7.13) 0.0057 
Female 8 (0.6) 0.3–1.2 1366 (99.4) 98.8–99.7 
Age group 
Up to 29 6 (0.8) 0.3–1.9  701 (99.2) 98.1–99.7 1.79 (0.62–5.12) 
0.5505 30 to 59 15 (1.2) 0.7–2 1263 (98.8) 98.0–99.3 1.29 (0.55–3.03) 
60 and + 8 (1.5) 0.7–3.1  519 (98.5) 96.9–99.3  
Risk factors and comorbidities 
Smoking 
Yes 9 (2.6) 1.3–5 340 (97.4) 95–98.7 
2.79 (1.28–6.08) 0.0158 
No 20 (0.9) 0.6–1.5 2143 (99.1) 98.5–99.4 
Sedentary lifestyle 
Yes 14 (1.5) 0.8–2.6 926 (98.5) 97.4–99,2 
1.56 (0.76–3.22) 0.3067 
No 15 (1) 0.6–1.6 1557 (99) 98.4–99.4 
Overweight 
Yes 6 (1.1) 0.5–2.5 532 (98.9) 97.5–99.5 
0.96 (0.39–2.34) 0.8953 
No 23 (1.2) 0.8–1.8 1951 (98.8) 98.2–99.2 
AMI 
Yes 4 (6.1) 2–15.6 62 (93.9) 84.4–98 
5.93 (2.12–16.56) 0.0014 
No 25 (1) 0.7–1.5 2421 (99) 98.5–99.3 
Stroke 
Yes 3 (4.8) 1.3–14.4 59 (95.2) 85.6–98.7 
4.56 (1.42–14.66) 0.0317 
No 26 (1.1) 0.7–1.6 2424 (98.9) 98.4–99.3 
CKD 
Yes 8 (7.2) 3.4–14.1 103 (92.8) 85.9–96.6 
8.24 (3.73–18.19) <0.0001 
No 21 (0.9) 0.6–1.4 2380 (99.1) 98.6–99.4  
DF 
Yes 17 (23) 14.3–34.5 57 (77) 65.5–85.7 46.67 (23.13–
94.16) 
<0.0001 
No 12 (0.5) 0.3–0.9 2426 (99.5) 99.1–99.7  
n—number of individuals; P%—Percent Prevalence; CI—Confidence interval; PR—Prevalence ratio; 
“p”—p value by Pearson's chi-square test and Yates correction. Source: SisHiperdia (Department of 
Informatics of the National Health System - DATASUS), 2019. 
Table 3. Prevalence % of DM-related amputations in the type 2 DM population, stratified by gender, 
age group, smoking, physical inactivity, overweight, acute myocardial infarction (AMI), stroke, 
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n (P%) 95% CI 
No 
n (P%) 95% CI 
PR (95% CI) “p” 
Amputation 104 (1.5) 1.2–1.8 6891 (98.5) 98.2–98.8   
Gender 
Male 66 (2.3) 1.8–2.9 2809 (97.7) 97.1–98.2 
2.49 (1.67–3.7) <0.0001 
Female 38 (0.9) 0.7–1.3 4082 (99.1) 98.7–99.3 
Age group 
Up to 29 3 (0.9) 0.2–2.9  321 (99.1) 97.1–99.8 2.33 (0.73–7.44) 
0.0084 30 to 59 55 (1.2) 0.9–1.6 4482 (98.8) 98.4–99.1 1.78 (1.21–2.62) 
60 and + 46 (2.2) 1.6–2.9  2088 (97.8) 97.1–98.4  
Risk factors and comorbidities 
Smoking 
Yes 26 (2.3) 1.5–3.4 1097 (97.7) 96.6–98.5 
1.74 (1.12–2.7) 0.0178 
No 78 (1.3) 1.1–1.7 5794 (98.7) 98.3–98.9  
Sedentary lifestyle 
Yes 64 (1.9) 1.5–2.4 3338 (98.1) 97.6–98.5 
1.69 (1.14–2.5) 0.0107 
No 40 (1.1) 0.8–1.5 3553 (98.9) 98.5–99.2  
Overweight 
Yes 33 (1.2) 0.8–1.7 2690 (98.8) 98.3–99.2 
0.73 (0.48–1.1) 0.1570 
No 71 (1.7) 1.3–2.1 4201 (98.3) 97.9–98.7 
AMI 
Yes 18 (11.6) 7.2–18 137 (88.4) 82–92.8 
9.24 (5.7–14.96) <0.0001 
No 86 (1.3) 1–1.6 6754 (98.7) 98.4–99 
Stroke 
Yes 17 (11.2) 6.8-17.6 135 (88.8) 82.4-93.2 
8.8 (5.37-14.42) <0.0001 
No 87 (1.3) 1-1.6 6,756 (98.7) 98.4-99 
CKD 
Yes 20 (6.8) 4.3–10.5 272 (93.2) 89.5–95.7 
5.47 (3.4–8.77) <0.0001 
No 84 (1.3) 1–1.6 6619 (98.7) 98.4–99 
DF 
Yes 71 (31.1) 25.3–37.6 157 (68.9) 62.4–74.7 63.86 (43.18–
94.44) 
<0.0001 
No 33 (0.5) 0.3–0.9 6734 (99.5) 99.1–99.7  
n—number of individuals; P%—Percent Prevalence; CI—Confidence interval; PR—Prevalence ratio; 
“p”—p value by Pearson's chi-square test and Yates correction. Source: SisHiperdia (Department of 
Informatics of the National Health System - DATASUS), 2019. 
Table 4. Prevalence % of DM-related amputations in the population with DM and hypertension, 
stratified by gender, age group, smoking, physical inactivity, overweight, acute myocardial infarction 
(AMI), stroke, chronic kidney disease (CKD), and diabetic foot (DF) in the state of Espírito Santo, 
Brazil, from 2003 to 2012. 
Variables 
Yes 
n (P%) 95% CI 
No 
n (P%) 95% CI 
PR (95% CI) “p” 
Amputation 1224 (2.2) 2.1–2.4 53,465 (97.8) 97.6–97.9   
Gender 
Male 492 (2.8) 2.6-3.1 16,911 (97.2) 96.9–97.4 
1.44 (1.29-1.61) <0.0001 
Female 732 (2) 1.8-2.1 36,554 (98) 97.9–98.2 
Age Group 
Up to 29 23 (2.5) 1.6–3.7 908 (97.5) 96.3–98.4  
0.0540 30 to 59 572 (2.1) 1.9–2.3 26,848 (97.9) 97.7–98.1 1.18 (0.78–1.79) 
60 and + 629 (2.4) 2.2–2.6  25,709 (97.6) 97.4–97.8 1.03 (0.69–1.56) 
Risk factors and comorbidities 
Smoking 
Yes 392 (4.4) 4–4.9 8434 (95.6) 95.1–96 
2.45 (2.18–2.75) <0.0001 
No 832 (1.8) 1.7–1.9 45,031 (98.2) 98.1–98.3  
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Sedentary lifestyle 
Yes 686 (2.4) 2.3–2.6 27,464 (97.6) 97.4–97.7 
1.20 (1.08–1.34) 0.0013 
No 538 (2) 1.9–2.2 26,001 (98) 97.8–98.1  
Overweight 
Yes 565 (2) 1.9–2.2 27,271 (98) 97.8–98.1 
0.83 (0.74–0.92) 0.0009 
No 659 (2.5) 2.3–2.6 26,194 (97.5) 97.4–97.7 
AMI 
Yes 369 (6.8) 6.1–7.5 5,078 (93.2) 92.5–93.9 
3.9 (3.46–4.39) <0.0001 
No 855 (1.7) 1.6–1.9 48,387 (98.3) 98.1–98.4  
Stroke 
Yes 362 (6.8) 6.2–7.5 4,951 (93.2) 92.5–93.8 
3.9 (3.46–4.4) <0.0001 
No 862 (1.7) 1.6–1.9 48,514 (98.3) 98.1–98.4  
CKD 
Yes 396 (8.5) 7.7–9.4 4250 (91.5) 90.6–92.3 
5.15 (4.59–5.78) <0.0001 
No 828 (1.7) 1.5–1.8 49,215 (98.3) 98.2–98.5  
DF 
Yes 726 (29.3) 27.5–31.1 1754 (70.7) 68.9–72.5 30.69 (27.58–
34.15) 
<0.0001 
No 498 (1) 0.9–1 51,711 (99) 99–99.1 
n—number of individuals; P%—Percent Prevalence; CI—Confidence interval; PR—Prevalence ratio; 
“p”—p value by Pearson's chi-square test and Yates correction. Source: SisHiperdia (Department of 
Informatics of the National Health System - DATASUS), 2019 
4. Discussion 
4.1. DM-Related Amputations 
The prevalence of DM-related amputations in the analyzed population was higher in type 2 DM, 
n = 104, 1.5% (95% confidence interval (CI) 1.2–1.8), and even higher in the coexistence of DM and 
hypertension, n = 1224, 2.2% (95% CI 2.1–2.4). 
Our results are similar to those found in Canada, where the estimated prevalence of type 2 DM 
amputations was 1.4% [25]. In England, the age- and sex-adjusted incidence of minor amputations 
was 1.2 per 100,000 inhabitants in type 1 DM and 4.1 per 100,000 inhabitants in type 2 DM [26].  
In Italy, a study reported a crude lower limb amputation rate of 20.4 per 100,000 inhabitants, 
247.2 for 100,000 people with DM, and 8.6 for those without DM, demonstrating an increased risk of 
amputations in people with DM [27].  
In type 1 diabetics, the lower prevalence of amputations may be associated with better glycemic 
control, related to insulin use, slowing the progression of the pathophysiological pathway of 
microvascular complications, and associated with improved skin microcirculation and lower 
incidence of ischemic foot ulcers [28]. The higher prevalence among people with DM and 
hypertension may be associated with the fact that hypertension significantly contributes to 
microvascular and macrovascular changes in DM, responsible for the pathophysiological changes in 
these cases [29]. 
In Minas Gerais, diabetic patients undergoing major amputation in a hospital in Belo Horizonte 
had a high prevalence of hypertension (54.7%) and an increased risk of a major amputation related 
to hypertension [30]. A cohort study conducted at a university hospital in the state of Pará, Brazil, 
with 711 individuals, showed an association of hypertension with the severity of PAD and a 
consequent increased risk for amputation [31].  
A higher prevalence of amputations was found in males in all types of DM, with a statistically 
significant association. These findings converge with the Eurodiale study, which also demonstrated 
a higher risk and higher prevalence of male amputations [5,32].  
A study conducted in the state of São Paulo also found a higher prevalence in males (57.5% to 
61.3%), but without a statistical correlation with increased risk [33]. In Santa Catarina, the data are 
similar to those found in this study, with 64.9% of DM-related amputations occurring in males [34]. 
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The higher prevalence of injuries and amputations in males may be associated with the fact that 
men are more reluctant to seek health care and follow preventive recommendations, and tend to be 
more neglectful of their own health [35,36]. 
However, recent research has shown that women with a history of DF have an equal or slightly 
higher risk for cardiovascular events, CKD, and mortality compared to men, with an emphasis on 
the increased risk of ischemic stroke [37]. Inequalities in treatment related to gender or socioeconomic 
conditions, hormonal factors, genetic predisposition linked to sexual dimorphism, alone or together, 
may be associated with an increased risk of cardiovascular complications in women [37–39]. 
In the age group above 60 years, the prevalence of amputations in the population studied was 
higher among individuals with type 1 DM; however, in the population with concomitant DM and 
hypertension, a slightly higher prevalence was observed in the age group up to 29 years. A statistical 
analysis showed a significant association only in type 2 DM. 
In Belo Horizonte, an increase in the prevalence of amputations and mortality was shown in 
diabetic patients with advancing age (between 31 and 60 years n = 40 (15.4%), between 61 and 80 
years n = 79 (22.7%) and older than 80 years n = 16 (38.1%), as well as an association with a higher risk 
of amputation in advanced age (odds ratio (OR) 1.05, p < 0.001), which corroborates our findings [30]. 
In Germany, researchers have shown a high prevalence and higher risk of PAD among type 1 
diabetic elderly patients with a mean age of 62.6 years and in type 2 DM with a mean age of 71.3 years 
(p < 0.0001), probably related to a longer disease course [40]. 
Hypertension has been associated with accelerated progression of microvascular and 
macrovascular complications in the young adult population with associated DM and hypertension 
[29,41,42]. However, it was not possible to analyze, based on the information available in the 
researched database, whether the increased prevalence of amputations in young diabetic adults was 
directly related to hypertension.  
A high prevalence of DM-related amputation was observed when correlated with smoking, 
physical inactivity, AMI, stroke, CKD, and DF in type 1 DM, type 2 DM, and concomitant 
hypertension DM, with a significant statistical association, with an excess of a sedentary lifestyle in 
DM type 1. 
The prevalence of amputations was lower in the overweight population with type 1 DM, type 2 
DM, and concomitant hypertension and DM, presenting a statistically significant association only in 
the diabetic population with hypertension. 
Converging with our findings, a cohort study in a Saudi Arabia population of 62,681 diabetics 
over 25 years of age reported that smoking, CKD, coronary heart disease, cerebrovascular disease, 
and obesity were associated with a higher risk of foot complications in people with DM, including 
gangrene and amputations [43]. 
In Taiwan, a sample of 1,588 persons with type 2 DM undergoing non-traumatic amputation 
showed a higher prevalence of amputations in patients with a history of coronary artery disease and 
stroke [44]. 
The results of this study also converge with those found in Ghana, where the average incidence 
of foot problems (including amputations) was 8.39% in 7,383 people with diabetes with increased risk 
in males (OR = 2.51), in hypertension (OR = 1.14), nephropathy (OR = 2.15), and previously diagnosed 
DF (OR = 3.24), all with a statistically significant correlation. However, the increased risk for body 
mass index (BMI) increased by 5 kg/m² (OR = 3.2), which differs from the results found in the diabetic 
population with coexisting hypertension [45]. 
In Brazil, the Brazupa study evaluated 1,455 individuals with diabetes, and also showed a higher 
prevalence of amputations in males (70.9%; p< 0.001) in the elderly (mean age 60.5 years; p < 0.001), 
in type DM 2 (95.8%; p = 0.017), CKD (33.3%; p = 0.001), heart disease (36.4%; p = 0.023), previous DF 
changes (96.7%; p < 0.001), and among smokers (26.1% p = 0.52); however, the last one did not have a 
statistically significant association [46]. 
Smoking has been associated as a triggering or aggravating factor for type 2 DM, due to its effects 
on cortisol concentrations, inflammatory markers, oxidative stress, insulin resistance, as well as an 
increase in fasting glucose, contributing to vascular and neuropathic complications [47,48]. 
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Sedentary lifestyle and smoking were associated with increased cardiovascular risk [49]. A 
sedentary lifestyle is related to increased insulin resistance and glycemic rates with 
pathophysiological repercussions on diabetic neuropathy and on micro and macrovascular changes 
[50]. 
Diabetics with mild to moderate CKD are more at risk for DF and amputations [51], and greater 
morbidity and mortality related to cardiovascular and cerebrovascular diseases were also associated, 
which justifies the findings of this research [52]. 
Vascular disease is related to a series of pathophysiological mechanisms that affect the structure 
and function of sago vessels, leading to arterial failure, the main risk factors being advanced age, DM, 
hypertension, hyperlipidemia, and smoking [53]. 
A high prevalence of vascular diseases has been shown in people with CKD, and even higher in 
albuminuria [54]. When CKD is associated with DM, a higher prevalence of critical ischemia and 
lower-limb amputations was observed [55]. Studies have pointed out that PAD and arterial stiffness 
are associated with worsening the progression of kidney disease and cardiovascular disease [56,57]. 
The frequency of amputations among people with diabetes is 10 to 20 times higher compared to 
the general population [7]. Each year, about one million individuals with diabetes undergo lower-
limb amputation worldwide, accounting for about three amputations per minute [8]. DF is the 
leading cause of non-traumatic lower-limb amputations worldwide. In China, an amputation rate of 
19.03% has been demonstrated in individuals with DM, which is 15 times higher than in those 
without diabetes [58].  
Poor glycemic control, smoking, presence of hyperkeratosis, callus, and foot deformities, as well 
as visual impairment, CKD, previous history of ulcer and amputation, NP and PAD are the main risk 
factors for DF ulcers and amputations [59]. 
PAD is directly related to amputations, and its risk factors include DM, hypertension, 
dyslipidemia, smoking, and obesity. A recent meta-analysis showed an increased risk of PAD in 
patients with mild to moderate CKD [51]. Increased morbidity and mortality related to coronary and 
cerebrovascular disease were also found [52]. 
Often, diabetic people are affected by PAD and NP at the same time; however, the incidence of 
purely ischemic ulcers is not uncommon and is associated with local trauma [60]. The reduction in 
blood flow in the skin can make the vascular network more sensitive to occlusion during periods of 
high biomechanical pressure on the skin, contributing to the appearance of lesions and consequent 
amputation [61]. 
Foot ulcers and amputations are frequent and represent the main causes of morbidity and 
mortality in people with DM. Early detection and treatment of patients with DM and feet at risk for 
ulcers and amputations may delay or prevent adverse outcomes [59]. 
The high prevalence rates of DF-associated amputations, as evidenced by the present study, are 
justified by the direct association of DF injuries as precursors of amputations. DF is responsible for 
about 40% to 60% of non-traumatic lower-limb amputations in the world, with 85% of these 
amputations preceded by foot ulcers [4,5].  
Lower limb amputations are a sentinel event because the risk is influenced by the control of 
various factors (glycemic control, blood pressure control, smoking, etc.) and depends on the ability 
of health systems to track the risk, stratify it, and treat patients with ulcers and high-risk feet [2]. 
The prevalence of DF and the consequent amputation is directly related to the organization of 
health services and the investment made in the treatment of DM, which varies in each country, and 
is, therefore, more prevalent in poorer countries [62]. 
Late diagnosis is associated with poor health system performance, poor awareness of the 
disease, including among health professionals, and the silent progression of the disease, favoring the 
development of its complications. Governments and public health systems in many countries are still 
unaware of the current relevance of DM and their complications [01,18,63]. 
Given the factors that directly affect the development of DF, we realize the need that individuals 
with diabetes should have to maintain self-care and also the importance of the multidisciplinary team 
to ensure the quality of life of these patients, advising on the disease and its risks [64]. 
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Another research demonstrated the importance of a new look at the work processes, aiming at 
the individual's health instead of just looking at the disease [64]. In addition, it is essential to carry 
out educational methods with patients to improve health promotion and education practices, these 
practices are fundamental for the delivery of services and assistance to individuals with chronic 
diseases, ensuring the change in the care model [65,66]. 
Upon analyzing our findings, we realized the importance of implementing public health policies 
to monitor the control of risks related to DM. Ensuring comprehensive care, self-care education, and 
routine examination of the feet of people with diabetes, especially at the primary level of health care, 
can reduce these rates and consequently improve the health and quality of life of people with DM. 
Data collection regarding the complications of DM is an instrument capable of directing the 
attention of the public authorities and enables the planning of actions, directed to the prevention and 
control of comorbidities and risk factors.  
Comparative data on DM-related amputations by type of DM are relatively scarce, and in the 
databases searched, no Brazilian study evaluating and comparing the prevalence of amputations by 
type of DM in a population similar to this study was found, corroborating the relevance of this 
research. 
The results show that the prevalence of amputations related to DM in the state of Espírito Santo 
is still high, requiring constant monitoring and periodic review of strategies to implement public 
policies for managing this disease, and likewise, the development of new studies that separately 
analyze major and minor amputations, and identify the main difficulties encountered by the 
government, health professionals, patients and family members in coping with DM and its 
complications is required. 
Studies that analyze major and minor amputations separately are an innovative trend in the 
scientific field and are configured as a more effective strategy for the evaluation of health policy 
outcome indicators. 
5. Conclusions 
It was found a significant prevalence of DM-related amputations in the analyzed population, 
with a higher prevalence after 60 years of age and in males. An increased prevalence was correlated 
with smoking, physical inactivity, AMI, stroke, CKD, and DF, with statistically significant 
associations, with the exception of a sedentary lifestyle in type 1 DM. The prevalence of amputations 
was lower in the overweight population, indicating a statistically significant association only in 
people who live with concomitant diabetes and hypertension. 
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